Northrop Grumman Shares Up 28% YTD With Its Biggest Upside Not Yet in Guidance

"The February acceleration agreement converts what an earnings-call promise is into a signed commitment. CEO Kathy Warden had told investors on the Q4 call that 'funding for this acceleration has been approved as part of the reconciliation bill, and I am optimistic that we will come to an agreement with the Air Force this quarter.' That agreement arrived."

"The underlying business is performing well, with Q4 2025 revenue reaching $11.7 billion, up 10% year-over-year, a record backlog of $95.7 billion, and free cash flow of $3.3 billion, up 26% from the prior year, all while the Aeronautics Systems business alone grew 18% in Q4."

"2026 guidance calls for $43.5-$44 billion in sales and free cash flow of $3.1-$3.5 billion, with the B-21 ramp not yet in those numbers. The defense spending environment is the strongest Warden says she has seen: 'This is the most robust demand environment I've seen in my career.'"

Northrop Grumman has regained investor confidence following three consecutive earnings beats after a $477M B-21 loss provision. The company secured a signed Air Force acceleration agreement in February, converting previous earnings-call promises into a binding commitment. CEO Kathy Warden confirmed funding approval through reconciliation legislation. Financial impact remains minimal in 2026 but is expected to ramp significantly in 2027 and 2028, representing unpriced upside not yet included in guidance. Q4 2025 results demonstrate strong underlying business performance with $11.7 billion revenue (up 10% year-over-year), record $95.7 billion backlog, and $3.3 billion free cash flow (up 26%). Shares have risen 28% year-to-date to $735.18, already exceeding analyst consensus targets, reflecting market confidence in execution.

Read at 24/7 Wall St.